Handelsbanken Fonder’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498M Buy
1,959,262
+18,653
+1% +$4.35M 1.42% 13
2026
Q1
$474M Sell
1,940,609
-20,823
-1% -$4.85M 1.58% 10
2025
Q4
$406M Buy
1,961,432
+81,225
+4% +$16.1M 1.23% 12
2025
Q3
$349M Buy
1,880,207
+433,283
+30% +$74.2M 1.11% 12
2025
Q2
$221M Buy
1,446,924
+2,365
+0.2% +$364K 0.78% 16
2025
Q1
$240M Sell
1,444,559
-96,866
-6% -$15.2M 0.99% 16
2024
Q4
$223M Buy
1,541,425
+39,826
+3% +$6.17M 0.85% 15
2024
Q3
$243M Buy
1,501,599
+26,672
+2% +$4.25M 0.96% 13
2024
Q2
$216M Buy
1,474,927
+95,735
+7% +$14.2M 0.94% 14
2024
Q1
$218M Sell
1,379,192
-22,080
-2% -$3.51M 0.94% 15
2023
Q4
$220M Sell
1,401,272
-33,940
-2% -$5.2M 1.07% 12
2023
Q3
$224M Sell
1,435,212
-34,360
-2% -$5.67M 1.25% 8
2023
Q2
$243M Sell
1,469,572
-91,833
-6% -$14.8M 1.3% 9
2023
Q1
$242M Sell
1,561,405
-37,893
-2% -$6.12M 1.4% 9
2022
Q4
$283M Buy
1,599,298
+101,435
+7% +$17.5M 1.77% 5
2022
Q3
$245M Buy
1,497,863
+100,444
+7% +$17M 1.64% 6
2022
Q2
$248M Buy
1,397,419
+103,445
+8% +$18.4M 1.61% 6
2022
Q1
$229M Sell
1,293,974
-18,539
-1% -$3.15M 1.28% 10
2021
Q4
$225M Sell
1,312,513
-86,438
-6% -$14.2M 1.11% 13
2021
Q3
$226M Buy
1,398,951
+58,348
+4% +$9.95M 1.18% 12
2021
Q2
$221M Buy
1,340,603
+11,463
+0.9% +$1.9M 1.15% 11
2021
Q1
$218M Buy
1,329,140
+173,955
+15% +$28.1M 1.24% 8
2020
Q4
$182M Buy
1,155,185
+48,728
+4% +$7.19M 1.11% 10
2020
Q3
$165M Sell
1,106,457
-7,547
-0.7% -$1.12M 1.21% 11
2020
Q2
$157M Buy
1,114,004
+829,053
+291% +$121M 1.31% 8
2020
Q1
$37.4M Buy
284,951
+37,000
+15% +$5.25M 0.8% 39
2019
Q4
$36.2M Sell
247,951
-64,900
-21% -$8.8M 0.63% 51
2019
Q3
$40.5M Sell
312,851
-45,041
-13% -$5.93M 0.82% 38
2019
Q2
$49.8M Sell
357,892
-214,322
-37% -$29.7M 0.92% 31
2019
Q1
$80M Sell
572,214
-299,557
-34% -$40.1M 1.55% 16
2018
Q4
$113M Buy
871,771
+68,788
+9% +$9.6M 2.27% 6
2018
Q3
$111M Buy
802,983
+159,899
+25% +$21.2M 2.09% 7
2018
Q2
$78M Buy
643,084
+10,638
+2% +$1.33M 1.53% 12
2018
Q1
$81M Sell
632,446
-500
-0.1% -$67.6K 1.59% 12
2017
Q4
$88.4M Buy
632,946
+47,820
+8% +$6.66M 1.94% 8
2017
Q3
$76.1M Sell
585,126
-58,120
-9% -$7.7M 1.76% 12
2017
Q2
$85.1M Sell
643,246
-3,300
-0.5% -$421K 2.17% 6
2017
Q1
$80.5M Sell
646,546
-134,800
-17% -$16.1M 2.24% 6
2016
Q4
$90M Sell
781,346
-152,400
-16% -$17.6M 2.76% 3
2016
Q3
$110M Buy
933,746
+249,930
+37% +$30.3M 3.23% 2
2016
Q2
$82.9M Sell
683,816
-34,500
-5% -$3.92M 3.4% 2
2016
Q1
$77.7M Sell
718,316
-579,658
-45% -$60M 3.31% 2
2015
Q4
$133M Buy
+1,297,974
New +$131M 2.58% 2

Other funds holding JNJ

Handelsbanken Fonder's JNJ Position: Q2 2026 in Review

Handelsbanken Fonder increased its Johnson & Johnson (JNJ) stake by 0.96% in Q2 2026, buying an estimated $4.35M and bringing the position to 1,959,262 shares worth $498M. The position accounts for 1.42% of the portfolio, ranked #13.

Handelsbanken Fonder first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. 2,414 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Handelsbanken Fonder held 1,959,262 shares of Johnson & Johnson worth $498M as of Q2 2026.
  • Handelsbanken Fonder bought 18,653 Johnson & Johnson shares in Q2 2026, an estimated $4.35M.
  • Johnson & Johnson made up 1.42% of Handelsbanken Fonder's portfolio in Q2 2026, its #13 holding.
  • Handelsbanken Fonder first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • 2,414 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.